ECONOMIC EVALUATION OF TARGETED THERAPIES IN METASTATIC CLEAR RENAL CELL CARCINOMA IN CANADA
Author(s)
Nazha S, Prevost N, Tanguay S, Vanhuyse M, Dragomir A
McGill University Health Centre, Montreal, QC, Canada
OBJECTIVES: The objective of our study was to evaluate the economic impact of targeted therapies for the treatment of clear cell metastatic RCC in Canada using real-world data through the Canadian Kidney Cancer information system (CKCis). METHODS: The Canadian Kidney Cancer information system (CKCis) database was used to select the cohort of advances RCC collected prospectively over 15 centers of 6 Canadian provinces. Patients who had a diagnosis of RCC and metastatic RCC after January 1st
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PCN104
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Oncology
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now